David M. Livermore

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

Kanimozhi Kumarasamy, Mark A. Toleman, Timothy R. Walsh et al. · The Lancet Infectious Diseases · 2010 · 2.9K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study

Timothy R. Walsh, Janis Weeks, David M. Livermore et al. · The Lancet Infectious Diseases · 2011 · 1.2K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +11

The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii

Jane F. Turton, M. E. Ward, Neil Woodford et al. · FEMS Microbiology Letters · 2006 · 755 citations · Full text

Life Sciences, Microbiology, Molecular Genetics +17

Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection

Themoula Charalampous, Gemma L. Kay, Hollian Richardson et al. · Nature Biotechnology · 2019 · 723 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study

Hajo Grundmann, Corinna Glasner, Barbara Albiger et al. · The Lancet Infectious Diseases · 2016 · 677 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16